Leadership Team

Roy Jensen, MD Director, KU Cancer Center CEO, Midwest Cancer Alliance	Shrikant Anant, PhD Associate Director, Cancer Prevention and Control
Terance T. Tsue, MD, FACS Vice President and Physician-in-Chief, The University of Kansas Cancer Center	Teresa Christenson Associate Director Administration
Dan Dixon, PhD Co-Leader, Cancer Prevention and Survivorship	Edward Ellerbeck, MD, MPH Co-Leader, Cancer Control and Population Health
Gary Doolittle, MD Medical Director, Midwest Cancer Alliance	Carol Fabian, MD Associate Director, Clinical Research
Alan Gamis, MD Co-Leader, Drug Discovery, Delivery and Experimental Therapeutics Program	Andrew Godwin, PhD Deputy Director, The University of Kansas Cancer Center Director, Biospecimen Repository
Jennifer Klemp, PhD Co-leader, Cancer Prevention and Survivorship Program	Linheng Li, PhD Co-leader, Cancer Biology
Sally Maliski, PhD Associate Director, Equity	Matthew Mayo, PhD Associate Director, Shared Resources
Kristi Neufeld, PhD Co-Leader, Cancer Biology	Danny Welch, PhD Associate Director, Basic Science
Jeffrey Reene, MBA Chief Operating Officer	Scott Weir, PharmD, PhD Associate Director, Translational Research; Director, Institute for Advancing Medical Innovation
Christie Befort, PhD Co-leader, Cancer Control & Population Health	Steve Williamson, MD Director, Early-Phase Program, Clinical Research
Weijing Sun, MD Division Director, Medical Oncology; Associate Director for Clinical Research	Tara Lin, MD Medical Director, Clinical Trials Office
John Taylor, MD, MS Co-leader, Drug Discovery, Delivery and Experimental Therapeutics